sitamaquine has been researched along with Leishmaniasis in 2 studies
*Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, JL; Werbel, LM | 1 |
| Lombardo, M; Ortalli, M; Quintavalla, A; Rosso, C; Trombini, C; Varani, S | 1 |
2 other study(ies) available for sitamaquine and Leishmaniasis
| Article | Year |
|---|---|
Synthesis and antileishmanial activity of 6-methoxy-4-methyl-N-[6-(substituted-1-piperazinyl)hexyl]-8-quinolinamines and related compounds.
Topics: Aminoquinolines; Animals; Anthelmintics; Cricetinae; Drug Evaluation, Preclinical; Indicators and Reagents; Leishmania; Leishmaniasis; Male; Piperazines; Structure-Activity Relationship | 1983 |
Evaluation of synthetic substituted 1,2-dioxanes as novel agents against human leishmaniasis.
Topics: Animals; Chlorocebus aethiops; Dioxanes; Drug Design; Humans; Leishmania; Leishmaniasis; Parasitic Sensitivity Tests; Trypanocidal Agents; Vero Cells | 2019 |